logo

BIO.B

Bio-Rad Laboratories B·NYSE
--
--(--)
--
--(--)

BIO.B fundamentals

Bio-Rad Laboratories B (BIO.B) expects to report earnings on Feb 12, 2026, with estimated revenue of 693.17M (YoY +3.85%), and EPS at 2.7 (YoY -6.90%).
Revenue estimate / YoY
693.17M
+3.85%
EPS estimate / YoY
2.7
-6.90%
Report date
Feb 12, 2026
Earnings Call
5:00 PM on Feb 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

BIO.B has released its 2025 Q3 earnings report, with revenue of 653.00M, reflecting a YoY change of 0.51%, and net profit of -341.90M, showing a YoY change of -152.34%. The Sankey diagram below clearly presents BIO.B's revenue sources and cost distribution.

Key Indicators

Bio-Rad Laboratories B (BIO.B) key financial stats and ratios, covering profitability, financial health, and leverage.
Bio-Rad Laboratories B (BIO.B)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Bio-Rad Laboratories B (BIO.B)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Bio-Rad Laboratories B (BIO.B)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Bio-Rad Laboratories B (BIO.B) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Bio-Rad Laboratories B (BIO.B) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield